Sage Healthcare Press Releases - EIN Presswire - Press Release Distribution Service

Published on April 26, 2018 - 12:00 GMT

Mucomel® Phase II Results Selected to be Presented at ASCO

Spherium Biomed announced today the completion of its Phase I/IIa clinical trial of Mucomel®, for the prevention and treatment of oral mucositis. BARCELONA, SPAIN, April 26, 2018 /⁨EINPresswire.com⁩/ -- NEWS HIGHLIGHTS Spherium Biomed announced today the …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on February 20, 2018 - 13:00 GMT

Aviv Biomedical Announces Launch of New Website for their AVIV-BHS Bilirubin Hematofluorometer

WWW.AVIVBHS.COM LAKEWOOD, NEW JERSEY, USA, February 20, 2018 /⁨EINPresswire.com⁩/ -- Lakewood, New Jersey, 14 January 2018 – Aviv Biomedical proudly announces the launch of its new website at www.avivbhs.com showcasing the AVIV-BHS Bilirubin …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on January 11, 2018 - 14:28 GMT

Aviv Biomedical Announces the New Bilirubin Hematofluorometer

Providing New Opportunities for Detection and Management of Neonatal Jaundice, A Global Unmet Clinical Need LAKEWOOD, NEW JERSEY, USA, January 11, 2018 /EINPresswire.com/ -- Lakewood, New Jersey, 8 January 2018 – Aviv Biomedical (“Aviv”; www. …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on January 4, 2018 - 12:38 GMT

SAJE Pharma Announces a Revolutionary Multi-Drug Discovery Platform Focused on the Regulation of Nitrosylation Pathways

SAJE Pharma seeks licensing partners for its unique, novel and game changing drug discovery platform and drug candidate library of GSNOR inhibitors BALTIMORE, MARYLAND, USA, January 4, 2018 /EINPresswire.com/ -- Baltimore, Maryland, 4 January 2018 – SAJE …

Distribution channels: Banking, Finance & Investment Industry, Chemical Industry ...

Published on January 3, 2018 - 13:51 GMT

Zora Announces CERT - A Validated Test for Cardiovascular and Diabetes Risk Prediction

Zora releases a groundbreaking new test for prediction of cardiovascular and diabetes using novel biomarkers ESPOO, FINLAND, January 3, 2018 /EINPresswire.com/ -- Espoo, Finland, 3 January 2018 – Zora Biosciences Oy (“Zora”; www.zora.fi) announces the …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...